Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world
- PMID: 20053862
- PMCID: PMC2832466
- DOI: 10.1128/JCM.01815-09
Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world
Abstract
Helicobacter pylori is known to be a major cause of gastric carcinoma and peptic ulceration. cagA positivity and vacA's signal regions and mid-regions are well-characterized markers of H. pylori's virulence. Recently, an intermediate region has been identified as another strong marker of H. pylori-associated disease, and its i1 allele has been linked with severe diseases in colonized hosts. The goal of this study was to determine the prevalence of the intermediate alleles in H. pylori isolates from China, Turkey, and Uruguay and from U.S. Africans and to compare their distribution with other well-characterized virulence factors. Originally, 123 H. pylori strains were studied, but 3 were excluded due to the failure to amplify the intermediate region in these samples. Therefore, a total of 120 strains were analyzed: 30 Chinese isolates, 35 Turkish isolates, 30 Uruguayan isolates, and 25 U.S. African isolates. The s type and the m type were determined by PCR amplification. The i type was identified by PCR amplification and DNA sequencing. CagA status was determined by PCR methodology. There was a strong correlation among CagA positivity, s1, and i1 in Chinese, U.S. African, and Uruguayan isolates, but less correlation among these markers in Turkish isolates. A new intermediate variant (i3) was identified in 25.7% of Turkish strains and 3.3% of the Chinese strains. In summary, the distribution of CagA positivity and s1 correlated with the i1 in the three populations, except in the Turkish population, which showed a disproportionate representation of the i3 allele. Phylogenetic mapping confirmed the i-typing method previously defined and adopted for this study. The phylogenetic tree showed country-specific correlation with the intermediate region. Our results showed that the i1 allele is strongly associated with CagA positivity and the vacA s1 allele, suggesting its role as a virulence marker and potential predictor for clinical outcome.
Figures


Similar articles
-
Helicobacter pylori oipA genetic diversity and its associations with both disease and cagA, vacA s, m, and i alleles among Bulgarian patients.Diagn Microbiol Infect Dis. 2011 Dec;71(4):335-40. doi: 10.1016/j.diagmicrobio.2011.08.008. Epub 2011 Sep 19. Diagn Microbiol Infect Dis. 2011. PMID: 21937185
-
CagA and VacA polymorphisms do not correlate with severity of histopathological lesions in Helicobacter pylori-infected Greek children.J Clin Microbiol. 2009 Aug;47(8):2426-34. doi: 10.1128/JCM.00159-09. Epub 2009 Jun 17. J Clin Microbiol. 2009. PMID: 19535517 Free PMC article.
-
Association of Malaysian Helicobacter pylori virulence polymorphisms with severity of gastritis and patients' ethnicity.Helicobacter. 2012 Oct;17(5):340-9. doi: 10.1111/j.1523-5378.2012.00956.x. Epub 2012 Apr 25. Helicobacter. 2012. PMID: 22967117
-
Helicobacter pylori typing as a tool for tracking human migration.Clin Microbiol Infect. 2009 Sep;15(9):829-34. doi: 10.1111/j.1469-0691.2009.02967.x. Clin Microbiol Infect. 2009. PMID: 19702588 Free PMC article. Review.
-
Helicobacter pylori virulence factors as tools to study human migrations.Toxicon. 2010 Dec 15;56(7):1193-7. doi: 10.1016/j.toxicon.2010.01.018. Epub 2010 Feb 6. Toxicon. 2010. PMID: 20144640 Review.
Cited by
-
There Are No Insurmountable Barriers: Passage of the Helicobacter pylori VacA Toxin from Bacterial Cytoplasm to Eukaryotic Cell Organelle.Membranes (Basel). 2023 Dec 28;14(1):11. doi: 10.3390/membranes14010011. Membranes (Basel). 2023. PMID: 38248700 Free PMC article. Review.
-
Helicobacter pylori-related risk predictors of gastric cancer: The latest models, challenges, and future prospects.Cancer Med. 2020 Jul;9(13):4808-4822. doi: 10.1002/cam4.3068. Epub 2020 May 4. Cancer Med. 2020. PMID: 32363738 Free PMC article. Review.
-
Helicobacter pylori and Its Role in Gastric Cancer.Microorganisms. 2023 May 17;11(5):1312. doi: 10.3390/microorganisms11051312. Microorganisms. 2023. PMID: 37317287 Free PMC article. Review.
-
Genotypic diversity of the Helicobacter pylori vacA c region and its correlation with gastric disease outcomes.J Med Microbiol. 2025 Mar;74(3):001969. doi: 10.1099/jmm.0.001969. J Med Microbiol. 2025. PMID: 40052666 Free PMC article.
-
Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and its Pathogenicity.Toxins (Basel). 2019 Nov 19;11(11):677. doi: 10.3390/toxins11110677. Toxins (Basel). 2019. PMID: 31752394 Free PMC article. Review.
References
-
- Agha, A., and D. Y. Graham. 2005. Evidence-based examination of the African enigma in relation to Helicobacter pylori infection. Scand. J. Gastroenterol. 40:523-529. - PubMed
-
- Akopyants, N. S., S. W. Clifton, D. Kersulyte, J. E. Crabtree, B. E. Youree, C. A. Reece, N. O. Bukanov, E. S. Drazek, B. A. Roe, and D. E. Berg. 1998. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol. Microbiol. 28:37-53. - PubMed
-
- Atherton, J. C., P. Cao, R. M. Peek, M. K. R. Tummuru, M. J. Blaser, and T. L. Cover. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific VacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:17771-17777. - PubMed
-
- Azuma, T., S. Yamaaki, A. Yamakawa, M. Ohtani, A. Muramatsu, H. Suto, M. Y. Ito, M. Dojo, Y. Yamazaki, M. Kuriyama, Y. Keida, H. Higashi, and M. Hatakeyama. 2004. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J. Infect. Dis. 189:820-827. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Medical